ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
17 hedge funds and large institutions have $2.13M invested in Acorda Therapeutics in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$123K | |
| 2 | +$14.5K | |
| 3 | +$1.49K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$131 |
| 5 |
JP Morgan Chase
New York
|
+$15 |
Top Sellers
| 1 | -$17.6K | |
| 2 | -$7.56K | |
| 3 | -$2.79K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$73 |